Cargando…

Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy

OBJECTIVES: To investigate the association between diastolic function and the different beneficial effects of cardiac resynchronization therapy in patients with heart failure due to different causes. METHODS: The 104 enrolled patients were divided into an ischemic cardiomyopathy group (n=27) and a n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qi, Chen, Kang-Yu, Yu, Fei, Su, Hao, An, Chun-Sheng, Hu, Yang, Yang, Dong-Mei, Xu, Jian, Yan, Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2017
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525162/ https://www.ncbi.nlm.nih.gov/pubmed/28793004 http://dx.doi.org/10.6061/clinics/2017(07)08

Ejemplares similares

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy
por: Yu, Ziqing, et al.
Publicado: (2017)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Non-ischemic Cardiomyopathy Patients Derive Superior Mortality Benefit from Cardiac Resynchronization Therapy
por: Rosman, Jonathan, et al.
Publicado: (2007)

Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy
por: Obrzut, Sebastian, et al.
Publicado: (2010)

LV Dyssynchrony Is Helpful in Predicting Ventricular Arrhythmia in Ischemic Cardiomyopathy After Cardiac Resynchronization Therapy: A Preliminary Study
por: Tsai, Shih-Chuan, et al.
Publicado: (2016)

Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
por: Imamura, Teruhiko
Publicado: (2020)

Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
por: Beiert, Thomas, et al.
Publicado: (2018)

Defibrillator capability and all-cause mortality in patients receiving cardiac resynchronization therapy for non-ischemic cardiomyopathy: a Korean nationwide cohort study
por: Yang, P S, et al.
Publicado: (2023)

A novel risk model for mortality and hospitalization following cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy: the alpha-score
por: Yang, Shengwen, et al.
Publicado: (2020)

Dilemma with the route of venous access for hemodialysis catheter insertion in a patient with dilated ischemic cardiomyopathy treated by cardiac resynchronization therapy
por: Ashokananda, Devanahalli, et al.
Publicado: (2016)

Beneficial Effects of RNS60 in Cardiac Ischemic Injury
por: Zabielska-Kaczorowska, Magdalena A., et al.
Publicado: (2022)

Systolic heart failure and cardiac resynchronization therapy: a focus on diastole
por: Facchini, Emanuela, et al.
Publicado: (2014)

Influence of the Right Ventricular Lead Location on Ventricular Arrhythmias in Cardiac Resynchronization Therapy
por: Su, Hao, et al.
Publicado: (2018)

Reparative resynchronization in ischemic heart failure: an emerging strategy
por: Yamada, Satsuki, et al.
Publicado: (2014)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator
por: Bang, Ji Hyun, et al.
Publicado: (2015)

Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy
por: Chung, Yoo-Ri, et al.
Publicado: (2017)

Cardiac resynchronization in pacing-associated cardiomyopathy: Is it time to upgrade?
por: Hutchinson, Mathew D.
Publicado: (2021)

Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy
por: Zhang, Zhi-hua, et al.
Publicado: (2020)

Cardiac resynchronization therapy with a defibrillator in non‐ischemic and ischemic patients for primary and secondary prevention of sudden cardiac death: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2023)

Identification and validation of ferroptosis-related genes and immune infiltration in ischemic cardiomyopathy
por: Huang, Kai, et al.
Publicado: (2023)

The association between ECV and microcirculation perfusion abnormalities in non-ischemic dilated cardiomyopathy
por: Ali, Aamir, et al.
Publicado: (2014)

Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Beneficial effects of neuronal ATF6 activation in permanent ischemic stroke
por: Li, Xuan, et al.
Publicado: (2022)

Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models
por: Lu, Danbo, et al.
Publicado: (2019)

Is routine cardiac MRI justifiable in patients with non-ischemic cardiomyopathy?
por: Kozeski, Gorgi, et al.
Publicado: (2009)

Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
por: Graber, Michael, et al.
Publicado: (2022)

Cardiac MR feature tracking identifies abnormal biventricular global strain values in biopsy-proven non-ischemic cardiomyopathies
por: Collins, Jeremy D, et al.
Publicado: (2015)

Repeated Intravenous Administration of Mesenchymal Stromal Cells Produces Cumulative Beneficial Effects in Chronic Ischemic Cardiomyopathy
por: Tang, Xian-Liang, et al.
Publicado: (2023)

Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
por: Müller, By Alison L, et al.
Publicado: (2010)

Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy
por: Zhou, Mei, et al.
Publicado: (2023)

Left Ventricular Diastolic Dysfunction in Ischemic Stroke: Functional and Vascular Outcomes
por: Park, Hong-Kyun, et al.
Publicado: (2016)

Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy
por: Yang, Lin, et al.
Publicado: (2020)

Multimodality Imaging in Ischemic Cardiomyopathy
por: Prior, John O., et al.
Publicado: (2014)

Plasma free fatty acid is associated with ischemic cardiomyopathy and cardiac dysfunction severity in systolic heart failure patients with diabetes
por: Wei, Xue-Mei, et al.
Publicado: (2021)

Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy
por: Kim, Eun Kyoung, et al.
Publicado: (2016)

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation
por: Nagata, Yoshiki, et al.
Publicado: (2017)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6aj43et9lprecgn9mru1mv5itc